SAEVA Proceedings 2015 | Page 101

South African Equine Veterinary Association Congress 2015  Protea Hotel  Stellenbosch Samples should be submitted for worm egg count, wet smear examination for cyathostomin larvae, occult blood and potentially bacteriology/clostridial toxin analysis. Be aware that horses with chronic diarrhoea are more likely to shed Salmonella spp and give a positive culture/PCR. Routine haematology: common findings associated with chronic diarrhoea Anaemia of chronic disease is a common finding in horses with chronic diarrhoea. Chronic disease will result in a packed cell volume (PCV) in the range of 20-30%. The anaemia occurs due to a combination of reduced red cell lifespan, reduced marrow responsiveness (as a result of either decreased erythropoietin or reduced response to erythropoietin), and reduced free iron. Anaemia due to chronic disease will occur within approximately 10 days of the start of the disease process. Lower PCVs (<20%) will usually be due to haemolytic or haemorrhagic disorders. White cell parameters may be normal or show changes consistent with chronic inflammation. Mature neutrophilia can occur with excitement, physiologic stress or administration of corticosteroids and is often indicative of a non-specific inflammatory response. High counts, in conjunction with elevated fibrinogen and globulins, are more suggestive of an infectious process and are also a common finding in larval cyathostominosis. Monocytosis is an indication of a chronic inflammatory process. Eosinophilia is uncommon but may rarely be associated w ith a significant parasite burden or systemic disease process such as multisystemic eosinophilic epitheliotrophic disease (MEED). Leukaemia is rarely seen with lymphoma, but very occasionally a marked lymphocytosis with abnormal cells can occur. Acute phase proteins (APP) should be assessed. Serum amyloid A (SAA) is a positive major APP and has low concentrations in the plasma of healthy horses. Concentrations of SAA increase rapidly, often to greater than 100-fold, during the acute phase response and there is a rapid decrease in concentration with disease resolution. Normal SAA values in healthy horses range from 0-20mg/l and increase within 12 hours of tissue injury, to peak at 24-48 hours. Fibrinogen is relatively insensitive as it takes several days to increase after the induction of inflammation and 3-6 days to reach a peak response. Use in conjunction with SAA can help to monitor progression of the disease process and response to treatment. Protein electrophoresis identifies elevations in specific globulin fractions. - Alpha 2 globulins include the acute phase proteins - Beta 1 globulins are associated with large strongyle and larval cyathostomin activity - Beta 2 globulins are associated with hepatopathy - Elevation in gamma globulins occurs in response to bacterial or viral infections Some neoplasms, such as lymphosarcoma, can result in a monoclonal gammopathy (usually seen as a significant elevation in beta or gamma globulins) due to uncontrolled production of a single immunoglobulin. In practice, protein electrophoresis is rarely helpful in providing a diagnosis for chronic diarrhoea. Routine biochemistry: common findings associated with chronic diarrhoea Total protein can vary associated with hydration status, depending on the severity of the diarrhoea, and any underlying inflammatory processes. The protein should be evaluated in conjunction with the hydration status of the horse. Albumin is a very useful parameter to monitor; marked hypoalbuminaemia (<20g/l) indicates significant protein loss and intestinal pathology. Non-specific chronic diarrhoea cases can have normal albumin values or only mild hypoalbuminaemia. Globulins may be elevated with chronic inflammation, parasites and neoplasia. Hypoglobulinaemia may occur with significant intestinal pathology and protein loss. Gamma glutamyl transferase (GGT) can be elevated in some cases with enteropathy, in the absence of liver disease. Other liver enzymes (GLDH, AST, ALP) and bile acids should be compared to rule out concurrent liver disease. 101